New gel targets wound infections in early safety trial

NCT ID NCT07379684

Recruiting now Disease control Sponsor: Macro Biologics, Inc. Source: ClinicalTrials.gov ↗

First seen Jan 31, 2026 · Last updated May 21, 2026 · Updated 16 times

Summary

This early-stage study tests a new gel called Amicidin-β, applied directly into infected surgical or traumatic wounds during a procedure. The main goal is to see if it is safe and easy for surgeons to use. About 44 adults with infected wounds will either get standard care alone or standard care plus the gel. Researchers will monitor for side effects and check if the gel enters the bloodstream.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SURGICAL WOUND INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

LifeBridge Health
RECRUITING

Baltimore, Maryland, 21215, United States
Lundquist Institute
RECRUITING

Torrance, California, 90502, United States
Snake River Research, PLLC
RECRUITING

Idaho Falls, Idaho, 83404, United States
The Ohio State University
RECRUITING

Columbus, Ohio, 43210, United States

Conditions

Explore the condition pages connected to this study.

SURGICAL WOUND INFECTION TRAUMATIC WOUND INFECTION